Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
H Yoshiji, S Nagoshi, T Akahane, Y Asaoka… - Journal of …, 2021 - Springer
The first edition of the clinical practice guidelines for liver cirrhosis was published in 2010,
and the second edition was published in 2015 by the Japanese Society of Gastroenterology …
and the second edition was published in 2015 by the Japanese Society of Gastroenterology …
COVID-19 and liver disease: mechanistic and clinical perspectives
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
[PDF][PDF] Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for …
PG Northup, JC Garcia‐Pagan, G Garcia‐Tsao… - …, 2021 - Wiley Online Library
• An overview of the current understanding of bleeding and thrombosis in cirrhosis.• An
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …
Acute-on-chronic liver failure clinical guidelines
In patients with cirrhosis and chronic liver disease, acute-on-chronic liver failure is emerging
as a major cause of mortality. These guidelines indicate the preferred approach to the …
as a major cause of mortality. These guidelines indicate the preferred approach to the …
Liver cirrhosis
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such
as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C …
as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C …
Current knowledge and management of portal vein thrombosis in cirrhosis
M Senzolo, G Garcia-Tsao, JC García-Pagán - Journal of hepatology, 2021 - Elsevier
Portal vein thrombosis (PVT) is an increasingly recognised complication of cirrhosis whose
incidence increases in parallel with the severity of cirrhosis. Several risk factors have been …
incidence increases in parallel with the severity of cirrhosis. Several risk factors have been …
AGA clinical practice update: coagulation in cirrhosis
JG O'Leary, CS Greenberg, HM Patton, SH Caldwell - Gastroenterology, 2019 - Elsevier
Description This expert review was commissioned and approved by the AGA Institute
Clinical Practice Updates Committee and the AGA Governing Board to provide timely …
Clinical Practice Updates Committee and the AGA Governing Board to provide timely …
[HTML][HTML] Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
During the early stages of the coronavirus disease 2019 (COVID-19) pandemic, EASL and
ESCMID published a position paper to provide guidance for physicians involved in the care …
ESCMID published a position paper to provide guidance for physicians involved in the care …
Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis
NM Intagliata, SH Caldwell, A Tripodi - Gastroenterology, 2019 - Elsevier
Portal vein thrombosis unrelated to solid malignancy is common in patients with cirrhosis,
but less frequently observed in patients without cirrhosis. Prompt diagnosis and …
but less frequently observed in patients without cirrhosis. Prompt diagnosis and …
[PDF][PDF] Single‐cell transcriptomic analysis reveals a hepatic stellate cell–activation roadmap and myofibroblast origin during liver fibrosis in mice
Background and Aims HSCs and portal fibroblasts (PFs) are the major sources of collagen‐
producing myofibroblasts during liver fibrosis, depending on different etiologies. However …
producing myofibroblasts during liver fibrosis, depending on different etiologies. However …